Prolonged red cell storage before transfusion increases extravascular hemolysis

Journal of Clinical Investigation

Volumn 127, Issue 1, 2017, Pages 375-382

  Rapido, Francesca ^a,b   Brittenham, Gary M ^c,d   Bandyopadhyay, Sheila ^a   Carpia, Francesca La ^a   L'Acqua, Camilla ^a   Mcmahon, Donald J ^d   Rebbaa, Abdelhadi ^a   Wojczyk, Boguslaw S ^a   Netterwald, Jane ^a   Wang, Hangli ^a   Schwartz, Joseph ^a   Eisenberger, Andrew ^d   Soffing, Mark ^e   Yeh, Randy ^e   Divgi, Chaitanya ^e   Ginzburg, Yelena Z ^f   Shaz, Beth H ^f   Sheth, Sujit ^e   Francis, Richard O ^a   Spitalnik, Steven L ^a   Hod, Eldad A ^a   more..

^a New York Presbyterian Hospital ^*  (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c Departments of Pediatrics   (United States)

^d Departments of Medicine   (United States)

^e NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^f NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HAPTOGLOBIN; HEMOGLOBIN; IRON; LACTATE DEHYDROGENASE; TRANSFERRIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILIRUBIN BLOOD LEVEL; CATABOLISM; CELL DAMAGE; CONTROLLED STUDY; DONOR SELECTION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HEMOLYSIS; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; ADVERSE EFFECTS; AGED; BLOOD; BLOOD STORAGE; CLINICAL TRIAL; COMPARATIVE STUDY; ERYTHROCYTE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; TIME FACTOR;

ADOLESCENT; ADULT; AGED; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; IRON; MALE; MIDDLE AGED; TIME FACTORS;

EID: 85008325072     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI90837     Document Type: Article

References (40)

1. Pfuntner A, Wier LM, Stocks C. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb162.pdf. Published September 2013. Accessed November 3, 2016.
2. Hess JR, Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Scientific problems in the regulation of red blood cell products. Transfusion. 2012;52(8):1827-1835.
3. Zimring JC. Established and theoretical factors to consider in assessing the red cell storage lesionBlood. 2015;125(14):2185-2190.
4. Remy KE, et al. Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta-analysis. Vox Sang. 2016;111(1):43-54.
5. Fergusson DA, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA. 2012;308(14):1443-1451.
6. Dhabangi A, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA. 2015;314(23):2514-2523.
7. Steiner ME, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015;372(15):1419-1429.
8. Lacroix J, et al. Age of transfused blood in critically ill adults. N Engl J Med. 2015;372(15):1410-1418.
9. Whitaker B, Rajbhandary S, Kleinman S, Harris A, Kamani N. Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey. Transfusion. 2016;56(9):2173-2183.
10. Glynn SA, Klein HG, Ness PM. The red blood cell storage lesion: the end of the beginning. Transfusion. 2016;56(6):1462-1468.
11. Flegel WA, Natanson C, Klein HG. Does prolonged storage of red blood cells cause harm? Br J Haematol. 2014;165(1):3-16.
12. Klein HG, Cortés-Puch I, Natanson C. More on the Age of Transfused Red Cells. N Engl J Med. 2015;373(3):283.
13. Goel R, et al. Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients. Transfusion. 2016;56(7):1690-1698.
14. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-342.
15. Cook JD, Marsaglia G, Eschbach JW, Funk DD, Finch CA. Ferrokinetics: a biologic model for plasma iron exchange in man. J Clin Invest. 1970;49(2):197-205.
16. Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion. 2008;48(6):1053-1060.
17. Hod EA, Spitalnik SL. Stored red blood cell transfusions: Iron, inflammation, immunity, and infection. Transfus Clin Biol. 2012;19(3):84-89.
18. Luten M, Roerdinkholder-Stoelwinder B, Schaap NP, de Grip WJ, Bos HJ, Bosman GJ. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion. 2008;48(7):1478-1485.
19. Brissot P, Ropert M, Le Lan C, Loréal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta. 2012;1820(3):403-410.
20. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112(2):219-230.
21. Hider RC. Nature of nontransferrin-bound iron. Eur J Clin Invest. 2002;32 Suppl1:50-54.
22. de Swart L, et al. Second international round robin for the quantification of serum nontransferrin- bound iron and labile plasma iron in patients with iron-overload disorders. Haematologica. 2016;101(1):38-45.
23. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425-4433.
24. Cortés-Puch I, et al. In a canine pneumonia model of exchange transfusion, altering the age but not the volume of older red blood cells markedly alters outcome. Transfusion. 2015;55(11):2564-2575.
25. Solomon SB, et al. Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood. 2013;121(9):1663-1672.
26. Hod EA, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood. 2010;115(21):4284-4292.
27. Prestia K, et al. Transfusion of stored blood impairs host defenses against Gram-negative pathogens in mice. Transfusion. 2014;54(11):2842-2851.
28. Hod EA, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin- bound iron. Blood. 2011;118(25):6675-6682.
29. Cross JH, et al. Oral iron acutely elevates bacterial growth in human serum. Sci Rep. 2015;5:16670.
30. Belotti A, et al. Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications. Leuk Res. 2015;39(1):88-91.
31. Hershko C. Mechanism of iron toxicity. Food Nutr Bull. 2007;28(4 Suppl):S500-S509.
32. Mollet IG, et al. Low dose iron treatments induce a dna damage response in human endothelial cells within minutes. PLoS One. 2016;11(2):e0147990.
33. Stark MJ, Keir AK, Andersen CC. Does non-transferrin bound iron contribute to transfusion related immune-modulation in preterms? Arch Dis Child Fetal Neonatal Ed. 2013;98(5):F424-F429.
34. L'Acqua C, et al. Red blood cell transfusion is associated with increased hemolysis and an acute phase response in a subset of critically ill children. Am J Hematol. 2015;90(10):915-920.
35. Dzik WH, et al. Factors affecting red blood cell storage age at the time of transfusion. Transfusion. 2013;53(12):3110-3119.
36. Blake JT, Hardy M, Delage G, Myhal G. Déjà-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Héma-Québec. Transfusion. 2013;53(7):1544-1558.
37. Fontaine MJ, Chung YT, Erhun F, Goodnough LT. Age of blood as a limitation for transfusion: potential impact on blood inventory and availability. Transfusion. 2010;50(10):2233-2239.
38. Grasas A, Pereira A, Bosch MA, Ortiz P, Puig L. Feasibility of reducing the maximum shelf life of red blood cells stored in additive solution: a dynamic simulation study involving a large regional blood system. Vox Sang. 2015;108(3):233-242.
39. Moroff G, Sohmer PR, Button LN. Proposed standardization of methods for determining the 24-hour survival of stored red cells. Transfusion. 1984;24(2):109-114.
40. Moore GL, Ledford ME, Merydith A. A micromodification of the Drabkin hemoglobin assay for measuring plasma hemoglobin in the range of 5 to 2000 mg/dl. Biochem Med. 1981;26(2):167-173.